Allscripts (MDRX) Reports In-Line Q2 EPS

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $386.5 million versus the consensus estimate of $403.13 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform
• Energy Fuels to acquire rare earth magnet maker VAC for $1.9 billion